» Articles » PMID: 3293764

Complete Pathologic Maturation and Regression of Stage IVS Neuroblastoma Without Treatment

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1988 Aug 15
PMID 3293764
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Spontaneous maturation of Stage IVS neuroblastoma has been postulated as a mechanism for its favorable prognosis, but this has rarely been documented pathologically. We report on a patient with congenital Stage IVS neuroblastoma who had extensive subcutaneous and bone-marrow involvement. Serial photographs, biopsies, and vanillomandelic acid determinations documented the tumor's initial progression which was followed by spontaneous maturation and involution of the patient's disease over a 6-year period. No cytotoxic therapy was administered. Favorable biologic prognostic factors were documented, including tumor DNA and protein analyses for N-myc amplification or overexpression and analysis for serum neuron-specific enolase and ferritin. Implications for management and therapy of Stage IVS neuroblastoma are discussed with reference to this case and the recent literature.

Citing Articles

Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Zhu S, Wang J, Zellmer L, Xu N, Liu M, Hu Y J Cancer. 2022; 13(9):2810-2843.

PMID: 35912015 PMC: 9330459. DOI: 10.7150/jca.72628.


Late Recurrence in Breast Cancer: To Run after the Oxen or to Try to Close the Barn?.

Demicheli R, Biganzoli E Cancers (Basel). 2021; 13(9).

PMID: 33922205 PMC: 8122713. DOI: 10.3390/cancers13092026.


Rethinking carcinogenesis: The detached pericyte hypothesis.

Baker S Med Hypotheses. 2020; 144:110056.

PMID: 32758893 PMC: 7688574. DOI: 10.1016/j.mehy.2020.110056.


Cancer associated fibroblast: Mediators of tumorigenesis.

Alexander J, Cukierman E Matrix Biol. 2020; 91-92:19-34.

PMID: 32450219 PMC: 7434664. DOI: 10.1016/j.matbio.2020.05.004.


The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease.

Parodi S, Ognibene M, Haupt R, Pezzolo A Diagnostics (Basel). 2020; 10(5).

PMID: 32429447 PMC: 7277942. DOI: 10.3390/diagnostics10050315.